AGP Executive Report
Last update: 6 hours agoCannabis & Mental Health: A large JAMA Health Forum study links teen marijuana use to more than double the risk of psychotic disorders and bipolar disorder by young adulthood, raising stakes as products get stronger and access expands. Substance Co-Use: A Vanderbilt-led study in Biological Psychiatry finds cannabis plus tobacco use is tied to lower cognitive performance in people at high clinical risk for psychosis, pointing to the need for earlier, more complete adolescent mental health support. Medical Cannabis Access: Illinois’ medical marijuana expansion takes effect, while Virginia pushes ahead with a timeline for retail recreational sales in 2027. Policy & Enforcement: The DEA kicks off a historic hearing on cannabis rescheduling, with filings arguing over drug testing and pharma “pocketbook” interests; meanwhile, local cases keep rolling—like a UK man charged after police seized suspected cocaine and cannabis, and a Michigan court order involving THC oil and cannabis possession. CBD in the Mix: A study on CBD and alcohol safety/tolerability is also in the news, keeping CBD’s clinical conversation active.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
